Abstract
Targeted interrogation of brain networks through invasive brain stimulation has become an increasingly important research tool as well as a therapeutic modality. The majority of work with this emerging capability has been focused on open-loop approaches. Closed-loop techniques, however, could improve neuromodulatory therapies and research investigations by optimizing stimulation approaches using neurally informed, personalized targets. Specifically, closed-loop direct electrical stimulation tests in humans performed during semi-chronic electrode implantation in patients with refractory epilepsy could help deepen our understanding of basic research questions as well as the mechanisms and treatment solutions for many neuropsychiatric diseases.
However, implementing closed-loop systems is challenging. In particular, during intracranial epilepsy monitoring, electrodes are implanted exclusively for clinical reasons. Thus, detection and stimulation sites must be participant- and task-specific. In addition, the system must run in parallel with clinical systems, integrate seamlessly with existing setups, and ensure safety features. A robust, yet flexible platform is required to perform different tests in a single participant and to comply with clinical settings.
In order to investigate closed-loop stimulation for research and therapeutic use, we developed a Closed-Loop System for Electrical Stimulation (CLoSES) that computes neural features which are then used in a decision algorithm to trigger stimulation in near real-time. To summarize CLoSES, intracranial EEG signals are acquired, band-pass filtered, and local and network features are continuously computed. If target features are detected (e.g. above a preset threshold for certain duration), stimulation is triggered. An added benefit is the flexibility of CLoSES. Not only could the system trigger stimulation while detecting real-time neural features, but we incorporated a pipeline wherein we used an encoder/decoder model to estimate a hidden cognitive state from the neural features. Other features include randomly timed stimulation, which percentage of biomarker detections produce stimulation, and safety refractory periods.
CLoSES has been successfully used in twelve patients with implanted depth electrodes in the epilepsy monitoring unit during cognitive tasks, spindle detection during sleep, and epileptic activity detection. CLoSES provides a flexible platform to implement a variety of closed-loop experimental paradigms in humans. We anticipate that probing neural dynamics and interaction between brain states and stimulation responses with CLoSES will lead to novel insights into the mechanism of normal and pathological brain activity, the discovery and evaluation of potential electrographic biomarkers of neurological and psychiatric disorders, and the development and testing of patient-specific stimulation targets and control signals before implanting a therapeutic device.
Competing Interest Statement
Multiple authors have patents pending in the area of closed-loop brain stimulation. AS has consulted with Neuroview Technology, Inc. DD receives research funding and honoraria from Medtronic. No other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This work was supported in part by the Tiny Blue Dot foundation, NIH grant K24-NS088568, NIH grant R01-NS062092, NIH grant R01NS079533 (WT), and the Defense Advanced Research Projects Agency (DARPA) under Cooperative Agreement Number W911NF-14-2-0045, issued by the Army Research Office contracting office in support of DARPA'S SUBNETS program. RZ was supported in part by the MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award. The views, opinions, and/or findings expressed are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
CLoSES code and example data is available on GitHub.
